Goldman Sachs Group »

Bicara Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Bicara Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 292.6M2.8M3M100k120k140k160k180k
Value ($)Share countHistorical BCAX position of Goldman Sachs Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.1M 180k 17.42
2024-09-30 $2.6M 102k 25.47

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Nvidia Corporation CMN (NVDA)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Amazon CMN (AMZN)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Broadcom CMN (AVGO)
Ishares Tr CMN (IWM)
Vanguard Index Fds CMN (VOO)
Ishares Tr CMN (IVV)
Alphabet CMN (GOOG)
Ishares Tr CMN (HYG)

View all positions for Goldman Sachs Group

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Tpg Gp A
Omega Fund Management
Adage Capital Partners GP
FMR
Braidwell
Deerfield Management Company
T. Rowe Price Associates
Fairmount Funds Management
BlackRock
Vanguard Group
Fil
Blackstone Group
Henderson Group

View all funds holding Bicara Therapeutics